Axel Becker

2.1k citations

28 papers · 1.7k indexed · 1 hit paper · h-index 16

Impact in

Otorhinolaryngology top 1%
- Head and Neck Cancer Studies
Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism

Papers in

Otorhinolaryngology 9
- Head and Neck Cancer Studies 9
Cancer Research 17
- Cancer, Hypoxia, and Metabolism 16

Co-authors: M. Molls Peter F. Stadler Jürgen Dunst Gabriele Hänsgen Juergen Dunst Volker Rudat Jens Overgaard Marianne Nordsmark
Journals: Strahlentherapie und Onkologie (12 papers)International Journal of Radiation Oncology*Biology*Physics (10 papers)Radiotherapy and Oncology (3 papers)Medical Oncology (1 paper)EJNMMI Research (1 paper)
Partner nations: Germany United States South Korea

In The Last Decade

Axel Becker

28 papers receiving 1.7k citations

Hit Papers

align trajectories log scale

Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study 2005 · 739 citations

Peers

Countries citing papers authored by Axel Becker

Since Specialization

Citations

This map shows the geographic impact of Axel Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Becker more than expected).

Fields of papers citing papers by Axel Becker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Becker. The network helps show where Axel Becker may publish in the future.

Co-authors

The 25 scholars most cited alongside Axel Becker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Axel Becker Line = papers co-authored together Axel Becker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Impact of 68Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy EJNMMI Research ·Christina Bluemel, 刘东润, Ken Herrmann, Iva Šimunović, Matthias Eiber, Pearly Swee Gek Teo, Andreas K. Buck, Andreas Schirbel, Thorsten Alexander Bley, Hans‐Juergen Wester, Daniel Vergho, Axel Becker	2016	71
2	Immunohistochemical Detection of HIF-1α and CAIX in Advanced Head-and-Neck Cancer Strahlentherapie und Onkologie ·Matthias Kappler, Helge Täubert, Hans-Jürgen Holzhausen, Annisa Nabiila, Swetlana Rot, Axel Becker, Thomas Kuhnt, Kathrin Dellas, Jürgen Dunst, Dirk Vordermark, Gabriele Hänsgen, Matthias Bache	2008	39
3	Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: Prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1α-related markers, and hemoglobin levels International Journal of Radiation OncologyBiologyPhysics ·Matthias Bache, Annisa Nabiila, Harun M. Said, Hans-Jürgen Holzhausen, Helge Täubert, Axel Becker, Thomas Kuhnt, Gabriele Hänsgen, Jürgen Dunst, Dirk Vordermark	2006	50
4	Phase II Trial of a Simultaneous Radiochemotherapy with Cisplatinum and Paclitaxel in Combination with Hyperfractionated-Accelerated Radiotherapy in Locally Advanced Head and Neck Tumors Medical Oncology ·Thomas Kuhnt, Axel Becker, Marc Bloching, Johannes Schubert, Günther Klautke, Rainer Fietkau, Juergen Dunst	2006	19
5	Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study Radiotherapy and Oncology ·Marianne Nordsmark, Søren M. Bentzen, Volker Rudat, David M. Brizel, Éric Lartigau, Peter F. Stadler, Axel Becker, Markus Adam, M. Molls, Juergen Dunst, David J. Terris, Jens Overgaard Hit paper breakdown →	2005	739
6	Aggressive Simultaneous Radiochemotherapy with Cisplatin and Paclitaxel in Combination with Accelerated Hyperfractionated Radiotherapy in Locally Advanced Head and Neck Tumors Strahlentherapie und Onkologie ·Thomas Kuhnt, Axel Becker, Steffi Pigorsch, Tanja Pelz, Marc Bloching, Yohanes Pembaptis Budi Bayuadi, Yurika Okamura, Gabriele Hänsgen, Jürgen Dunst	2003	28
7	Anemia and Elevated Systemic Levels of Vascular Endothelial Growth Factor (VEGF) Strahlentherapie und Onkologie ·Juergen Dunst, Axel Becker, Christine Lautenschläger, Silke Markau, Heike E. F. Becker, Kersten Fischer, G. Haensgen	2002	59
8	Oxygenation Measurements in Head and Neck Cancers during Hyperbaric Oxygenation Strahlentherapie und Onkologie ·Axel Becker, Thomas Kuhnt, Kathleen Keene, Y P Liu, Marc Bloching, J Dunst	2002	27
9	Tumor hypoxia, p53, and prognosis in cervical cancers International Journal of Radiation OncologyBiologyPhysics ·G. Haensgen, U. Krause, Axel Becker, Peter F. Stadler, Christine Lautenschlaeger, W Wohlrab, F.-W. Rath, M. Molls, Juergen Dunst	2001	55
10	Predictive Value of the Tumor Oxygenation by Means of pO2 Histography in Patients with Advanced Head and Neck Cancer Strahlentherapie und Onkologie ·Volker Rudat, Peter F. Stadler, Axel Becker, Bernhard Vanselow, Andreas Dietz, M. Wannenmacher, M. Molls, Jürgen Dunst, Horst Jürgen Feldmann	2001	73
11	Assoziation zwischen erhöhten Serum-VEGF-Werten und polarographisch gemessener Tumorhypoxie bei Patienten mit Kopf-Hals-Karzinomen Strahlentherapie und Onkologie ·Axel Becker, Peter F. Stadler, U. Krause, 夏立峰, Gabriele Hänsgen, Christine Lautenschläger, F.-W. Rath, M. Molls, Jürgen Dunst	2001	3
12	Tumor Hypoxia and Systemic Levels of Vascular Endothelial Growth Factor (VEGF) in Head and Neck Cancers Strahlentherapie und Onkologie ·Jürgen Dunst, Peter F. Stadler, Axel Becker, Thomas Kuhnt, Christine Lautenschläger, M. Molls, G. Haensgen	2001	45
13	Keine Assoziation zwischen p53-Überexpression und polarographisch gemessener Tumoroxygenierung bei Patienten mit Kopf-Hals-Karzinomen Strahlentherapie und Onkologie ·Axel Becker, Peter F. Stadler, U. Krause, Thomas Kuhnt, Gabriele Hänsgen, P. Dettmar, Horst Jürgen Feldmann, F.-W. Rath, M. Molls, Jürgen Dunst	2000	7
14	Influence of the hypoxic subvolume on the survival of patients with head and neck cancer International Journal of Radiation OncologyBiologyPhysics ·Peter F. Stadler, Axel Becker, Horst Jürgen Feldmann, Gabriele Hänsgen, Jürgen Dunst, Florian Würschmidt, M. Molls	1999	218
15	Oxygenation of cervical cancers during radiotherapy and radiotherapy + cis-retinoic acid/interferon International Journal of Radiation OncologyBiologyPhysics ·Jürgen Dunst, Gabriele Hänsgen, Christine Lautenschläger, Chinta Dewi Syahputri, Axel Becker	1999	43
16	Oxygenation of squamous cell carcinoma of the head and neck: comparison of primary tumors, neck node metastases, and normal tissue International Journal of Radiation OncologyBiologyPhysics ·Axel Becker, Gabriele Hänsgen, Marc Bloching, Kyle R. Eberlin, Christine Lautenschläger, Jürgen Dunst	1998	100
17	Hemoglobin level influences the oxygenation status of squamous cell carcinoma of the head and neck (SCCHN) International Journal of Radiation OncologyBiologyPhysics ·Axel Becker, Peter F. Stadler, Gabriele Hänsgen, Horst Jürgen Feldmann, M. Molls, Jürgen Dunst	1998	3
18	The hypoxic subvolume influences the prognosis of head and neck cancer International Journal of Radiation OncologyBiologyPhysics ·Peter F. Stadler, Axel Becker, Horst Jürgen Feldmann, Gabriele Hänsgen, Jürgen Dunst, M. Molls	1998	6
19	Oxygenierungsstatus von Plattenepithelkarzinomen der Kopf-Hals-Region Strahlentherapie und Onkologie ·Axel Becker, Gabriele Hänsgen, C. Richter, Jürgen Dunst	1998	10
20	Selektionsvorteil von p53-mutierten Zellen durch Hypoxie Strahlentherapie und Onkologie ·Jürgen Dunst, Axel Becker	1997	2

About Axel Becker

Axel Becker is a scholar working on Otorhinolaryngology, Cancer Research, Internal Medicine, Hepatology and Pulmonary and Respiratory Medicine, having authored 28 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (16 papers), Head and Neck Cancer Studies (9 papers), Angiogenesis and VEGF in Cancer (6 papers), Brain Metastases and Treatment (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Cancer-related Molecular Pathways (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). The work is most often cited by research in Otorhinolaryngology (288 citations), Cancer Research (928 citations), Radiology, Nuclear Medicine and Imaging (478 citations), Radiation (141 citations) and Pulmonary and Respiratory Medicine (474 citations). Axel Becker has collaborated with scholars based in Germany, United States and South Korea. Frequent co-authors include M. Molls, Peter F. Stadler, Jürgen Dunst, Gabriele Hänsgen, Juergen Dunst, Volker Rudat, Jens Overgaard, Marianne Nordsmark, Søren M. Bentzen and Éric Lartigau. Their work appears in journals such as Strahlentherapie und Onkologie, International Journal of Radiation Oncology*Biology*Physics, Radiotherapy and Oncology, Medical Oncology and EJNMMI Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact